Why the study?
Does pimobendan improve haemodynamic and hormonal parameters compared to enalapril in patients with mild to moderate heart failure?
Does pimobendan improve haemodynamic and hormonal parameters compared to enalapril in patients with mild to moderate heart failure?
Long-term therapy with pimobendan improved cardiac index and exercise capacity without signs of tolerance or significant hormonal changes compared to enalapril in mild to moderate heart failure.
No takes yet. Share an insight, caveat, or question.
Pimobendan may confer hemodynamic benefit over enalapril in mild-moderate HF; extends RCT support for long-term inodilator use.
Erlemeier et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: